Stempoint Capital Lp

13F Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 4M shares
Security Ownership: 7.2%

StemPoint Capital LP ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

2025-11-14 - StemPoint Capital LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4M shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO). This represents 7.2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
StemPoint Capital LP	7.2%		$3.38M	4M			$0.84	13G	9/30/2025	14 Nov 2025 10:00:24